These mutations often result in changes to residues that specifically bind DNA, leading to single amino acid substitutions that impair the function of wild-type p53.[39] In some cases, these mutations may confer new activities that allow tumor cells to bypass cell cycle checkpoints, enhancing their proliferation, division, invasion, and metastatic potential. The gene discussed is TP53; the disease is neoplasm.